G-15 (drug)

From WikiMD's WELLNESSPEDIA

A detailed overview of the G-15 drug, its uses, mechanism, and related information

G-15 is a synthetic compound that acts as a selective antagonist of the G protein-coupled estrogen receptor (GPER), also known as GPR30. It is primarily used in research settings to study the physiological and pathological roles of GPER in various tissues.

Chemical Structure and Properties[edit]

G-15 is a non-steroidal compound with a complex chemical structure that allows it to selectively bind to GPER without significant interaction with classical estrogen receptors, such as ERα and ERβ. This selectivity is crucial for its use in research, as it enables scientists to isolate the effects mediated by GPER.

Mechanism of Action[edit]

G-15 functions by competitively inhibiting the binding of endogenous estrogens to GPER. By blocking this receptor, G-15 can modulate various signaling pathways that are activated by GPER, including those involved in cell proliferation, apoptosis, and migration. This makes it a valuable tool for studying estrogen-related signaling in non-genomic pathways.

Research Applications[edit]

G-15 is widely used in preclinical studies to explore the role of GPER in different physiological processes and diseases. Some of the key areas of research include:

  • Cardiovascular System: Investigating the protective effects of GPER activation in cardiovascular diseases.
  • Cancer: Understanding the role of GPER in the progression of hormone-dependent cancers, such as breast and ovarian cancer.
  • Metabolic Disorders: Studying the impact of GPER on glucose metabolism and obesity.

Pharmacokinetics[edit]

The pharmacokinetic profile of G-15 is not extensively documented, as it is primarily used in vitro and in animal models. However, its solubility, stability, and bioavailability are important considerations for experimental design.

Safety and Toxicity[edit]

As G-15 is mainly used in laboratory research, comprehensive safety and toxicity data in humans are not available. Researchers handling G-15 should follow standard laboratory safety protocols to minimize exposure and potential risks.

Also see[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=G-15_(drug)&oldid=6626545"